National Health Investors (NHI) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Land & Buildings is soliciting proxies to elect two independent nominees to the board, citing concerns over board independence, conflicts of interest, and corporate governance at the company.
The solicitation follows a year of engagement with management, highlighting issues with board composition, particularly relationships with a major tenant, NHC.
Land & Buildings believes the company is undervalued due to outdated governance and lack of independent oversight, especially regarding the NHC lease renewal and acquisition opportunities.
The proxy contest seeks to replace two incumbent directors and support immediate board declassification for greater accountability.
Voting matters and shareholder proposals
Proposals include electing two Land & Buildings nominees, an advisory vote on executive compensation, ratification of the auditor, and two declassification proposals (one from the company, one from Land & Buildings).
Land & Buildings recommends voting for its nominees, for the unopposed company nominee, and for both declassification proposals.
Stockholders can vote for up to three nominees using the GOLD universal proxy card; voting for more invalidates the ballot.
Board of directors and corporate governance
The board is currently classified, with three classes of directors serving staggered terms.
Land & Buildings criticizes the board's long tenure, interlocking relationships, and conflicts of interest, especially with NHC.
The nominees, James Hoffmann and A. Adam Troso, are presented as highly qualified, independent, and free from conflicts.
Land & Buildings advocates for immediate board declassification to allow annual director elections.
Latest events from National Health Investors
- Normalized FFO per share rose 8.9% in Q4, with SHOP NOI up 125% and 2026 outlook strong.NHI
Q4 202527 Feb 2026 - Q2 FFO, FAD, and revenues rose, but net income fell; SHOP occupancy and guidance increased.NHI
Q2 20242 Feb 2026 - SHOP occupancy and NOI surged, but net income and FFO per share declined; liquidity remains strong.NHI
Q3 202416 Jan 2026 - Q4 and 2024 outperformed, with strong growth and 2025 guidance signaling further gains.NHI
Q4 20246 Jan 2026 - Strong financial results, board refreshment, and major governance reforms headline this year's proxy.NHI
Proxy Filing1 Dec 2025 - Board refreshment, strong financials, and governance reforms drive growth and shareholder value.NHI
Proxy Filing1 Dec 2025 - Board refreshment, strong returns, and governance enhancements drive long-term growth.NHI
Proxy Filing1 Dec 2025 - Proxy contest targets board independence, conflicts, and supports declassifying the board.NHI
Proxy Filing1 Dec 2025 - Board expanded with Robert W. Chapin, Jr.'s appointment; proxy details forthcoming.NHI
Proxy Filing1 Dec 2025